Vanguard Group Inc. Sells 89,960 Shares of Azenta, Inc. $AZTA

Vanguard Group Inc. trimmed its stake in Azenta, Inc. (NASDAQ:AZTA) by 2.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,425,449 shares of the company’s stock after selling 89,960 shares during the period. Vanguard Group Inc. owned about 9.68% of Azenta worth $153,298,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of AZTA. Russell Investments Group Ltd. grew its position in Azenta by 195.3% in the fourth quarter. Russell Investments Group Ltd. now owns 12,904 shares of the company’s stock valued at $645,000 after acquiring an additional 8,534 shares during the period. Invesco Ltd. grew its position in Azenta by 39.3% in the fourth quarter. Invesco Ltd. now owns 218,795 shares of the company’s stock valued at $10,940,000 after acquiring an additional 61,678 shares during the period. Raymond James Financial Inc. bought a new stake in Azenta in the fourth quarter valued at $2,331,000. CANADA LIFE ASSURANCE Co grew its position in Azenta by 13.5% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 43,554 shares of the company’s stock valued at $2,178,000 after acquiring an additional 5,182 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Azenta by 0.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company’s stock valued at $151,659,000 after acquiring an additional 26,929 shares during the period. 99.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Raymond James Financial upgraded Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 price objective for the company in a research report on Wednesday, August 6th. Needham & Company LLC cut their price objective on Azenta from $59.00 to $40.00 and set a “buy” rating for the company in a research report on Wednesday, May 7th. Evercore ISI set a $33.00 price target on Azenta and gave the company an “in-line” rating in a report on Tuesday, August 5th. Finally, Stephens assumed coverage on Azenta in a report on Tuesday, July 22nd. They issued an “equal weight” rating and a $35.00 price target for the company. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $35.75.

Azenta Stock Performance

Shares of AZTA opened at $29.77 on Thursday. The firm has a market capitalization of $1.36 billion, a price-to-earnings ratio of -12.30 and a beta of 1.59. The business’s fifty day moving average price is $31.31 and its two-hundred day moving average price is $33.15. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $55.63.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.06. The firm had revenue of $143.94 million for the quarter, compared to analyst estimates of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%.The business’s quarterly revenue was up .0% compared to the same quarter last year. During the same period last year, the company earned $0.14 EPS. As a group, research analysts forecast that Azenta, Inc. will post 0.53 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.